• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates

Market Research and Analysis of 2-(ethylsulfanyl)spiro[3.3]heptane-2-carboxylic acid (1480448-22-3)

The compound 2-(ethylsulfanyl)spiro[3.3]heptane-2-carboxylic acid, identified by the CAS registry number 1480448-22-3, has garnered significant attention in the chemical and pharmaceutical industries due to its unique structural properties and potential applications in drug development. This research brief provides an in-depth analysis of the latest advancements, market demands, and supplier dynamics surrounding this compound.

Recent studies have highlighted the compound's role as a promising lead molecule in the development of novel therapeutic agents. Its spirocyclic structure and sulfur-containing functional groups contribute to its potential as a bioactive compound, particularly in anti-inflammatory and anticancer drug discovery. Researchers have demonstrated its ability to modulate key cellular pathways, making it a valuable candidate for preclinical testing.

The global market for specialty chemicals, including compounds like 1480448-22-3, is driven by increasing demand from the pharmaceutical and biotechnology sectors. The growing emphasis on personalized medicine and the need for innovative drug delivery systems have further fueled interest in this compound. Market analysis indicates a steady rise in procurement requests from academic institutions, research laboratories, and pharmaceutical companies worldwide.

Suppliers specializing in fine chemicals and intermediates play a critical role in meeting the demand for 1480448-22-3. Key players in the industry are leveraging advanced synthetic methodologies to ensure consistent quality and scalability of production. The integration of green chemistry principles has also become a priority, as companies strive to minimize environmental impact while maintaining cost efficiency.

In conclusion, 2-(ethylsulfanyl)spiro[3.3]heptane-2-carboxylic acid (1480448-22-3) represents a compelling opportunity for innovation within the chemical and pharmaceutical sectors. As research progresses and market demands evolve, collaboration between academia, industry, and suppliers will be essential to unlocking its full potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)